期刊
EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 10, 期 8, 页码 1347-1359出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERN.10.93
关键词
cognitive-behavioral therapy; early intervention; olanzapine; omega-3 fatty acids; prodrome; psychosis; risperidone; ultra-high risk; ziprasidone
资金
- National Institute of Mental Health
- Pfizer
During recent decades, interest in the prevention of mental illnesses has increased. Improved diagnostic tools, the advent of atypical antipsychotic medications and the development of phase-specific psychosocial treatments have made intervention research in people at ultra-high risk for developing schizophrenia or a related psychotic disorder possible. Preliminary data suggest that low doses of atypical antipsychotic medications augmented by psychosocial treatments may delay the onset of psychosis in some individuals. Findings support further research for the establishment of best-practice standards.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据